Taming the T cell.

Biotechniques

Future Science Group, Unitec House, 2 Albert Place, London, UK.

Published: February 2020

Joseph Martin and Tristan Free explore the latest developments in the T-cell-based therapy CAR-T and the challenges that need to be overcome for them to become common clinical practice.

Download full-text PDF

Source
http://dx.doi.org/10.2144/btn-2020-0001DOI Listing

Publication Analysis

Top Keywords

taming cell
4
cell joseph
4
joseph martin
4
martin tristan
4
tristan free
4
free explore
4
explore latest
4
latest developments
4
developments t-cell-based
4
t-cell-based therapy
4

Similar Publications

Adaptations of neutrophils in cancer.

Immunity

January 2025

Vascular Biology and Therapeutics Program and Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. Electronic address:

There is a renewed interest in neutrophil biology, largely instigated by their prominence in cancer. From an immunologist's perspective, a conceptual breakthrough is the realization that prototypical inflammatory, cytotoxic leukocytes can be tamed to promote the survival and growth of other cells. This has sparked interest in defining the biological principles and molecular mechanisms driving the adaptation of neutrophils to cancer.

View Article and Find Full Text PDF

Perception of voice means acoustic electric conversion in the auditory system, and changes of external magnetic field can affect the neural activities by taming the channel current via some field components including memristor and Josephson junction. Combination of two capacitors via an electric component is effective to describe the physical property of artificial cell membrane, which is often used to reproduce the characteristic of electric activities in cell membrane. Involvement of two capacitive variables for two capacitors in the neural circuit can discern the effect of field diversity in the media in two sides of the cell membrane in theoretical way.

View Article and Find Full Text PDF

This study profiled global single cell-spatial-bulk transcriptome landscapes of hepatocellular carcinoma (HCC) ecosystem from six HCC cases and a non-carcinoma liver control donor. We discovered that intratumoral heterogeneity mainly derived from HCC cells diversity and pervaded the genome-transcriptome-proteome-metabolome network. HCC cells are the core driving force of taming tumor-associated macrophages (TAMs) with pro-tumorigenic phenotypes for favor its dominant growth.

View Article and Find Full Text PDF

TAM-ing the beast with IL-34 blockade.

Sci Immunol

November 2024

Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

mutation triggers IL-34 secretion by cancer stem cells, reprogramming macrophages to suppress T cells and promote tumor immune escape.

View Article and Find Full Text PDF

Background: Type I interferons (IFN-I) are potent alarm factors that initiate cancer cell elimination within tumors by the immune system. This critical immune response is often suppressed in aggressive tumors, thereby facilitating cancer immune escape and unfavorable patient outcome. The mechanisms underpinning IFN-I suppression in tumors are incompletely understood.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!